Dr. Burman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
110 Irving St NW
# 2A38
Washington, DC 20010Phone+1 202-877-2848Fax+1 202-877-2322
Education & Training
- National Capital ConsortiumResidency, Internal Medicine, 1972 - 1974
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1970 - 1972
- University of Missouri-Columbia School of MedicineClass of 1970
Certifications & Licensure
- MD State Medical License 1994 - 2026
- MO State Medical License 1970 - 2025
- DC State Medical License 1973 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Sutent Adjunctive Treatment of Differentiated Thyroid Cancer Start of enrollment: 2008 Apr 01
- The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma Start of enrollment: 2012 Sep 01
- Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors Start of enrollment: 2018 Jul 30
Publications & Presentations
PubMed
- Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA.Ivana Petrovic, Jonathan LoPresti, Shireen Fatemi, Andrew Gianoukakis, Kenneth Burman
The Journal of Clinical Endocrinology and Metabolism. 2024-11-18 - PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid Cancer.Leila Shobab, Deema Al-Souri, Liza Mathews-Kim, Matthew McCoy, William Kuenstner
Cancers. 2024-10-28 - Association of Free Thyroxine with Progression-Free Survival in Intermediate and High Risk Differentiated Thyroid Cancer.Raisa Ghosh, Sungyoung Auh, Sriram Gubbi, Padmasree Veeraraghavan, Craig Cochran
The Journal of Clinical Endocrinology and Metabolism. 2024-08-08
Other
- Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: The Frequency, Sites, Management by Security Agents, and Recommended Phys...Kenneth Burman, MD, Journal of Nuclear Medicine
https://www.doximity.com/articles/39ca59fe-47c4-421e-80bd-73330ab5813e
UpToDate, Wolters Kluwer Health - 2013-01-18 - Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: The Frequency, Sites, Management by Security Agents, and Recommended Phys...Kenneth Burman, MD, Journal of Nuclear Medicine
https://www.doximity.com/articles/39ca59fe-47c4-421e-80bd-73330ab5813e
UpToDate, Wolters Kluwer Health - 2012-07-11 - Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: The Frequency, Sites, Management by Security Agents, and Recommended Phys...Kenneth Burman, MD, Journal of Nuclear Medicine
https://www.doximity.com/articles/39ca59fe-47c4-421e-80bd-73330ab5813e
UpToDate, Wolters Kluwer Health - 2012-04-25 - Join now to see all
Press Mentions
- Tackle the Triglycerides to Reduce ASCVD Risk, ACC SaysJuly 28th, 2021
- First Thyroid Eye Disease Drug Wins over FDA PanelDecember 13th, 2019
- FDA Advisors Recommend CVD Event Reduction Claim for Icosapent EthylNovember 14th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: